IntelliProve raises €2.7M
Belgian healthtech company IntelliProve has raised €2.7 million in a seed funding round led by Miles Ahead, with participation from Wit-Gele Kruis, imec.istart and several business angels.
IntelliProve develops software that enables standard cameras in smartphones, laptops and other devices to measure health indicators without requiring additional equipment or physical contact. Through a 30-second facial scan, the technology provides six biomarkers: heart rate, heart rate variability (HRV), respiratory rate, systolic and diastolic blood pressure, and resonant breathing.
Healthcare systems face growing pressure from ageing populations, staff shortages and rising demand for care. IntelliProve aims to address this by enabling users to measure vital signs remotely through cameras in everyday devices. The company’s technology uses remote photoplethysmography (rPPG) to detect subtle changes in skin colour caused by blood circulation and movements associated with breathing, processing those signals with proprietary technologies designed to improve measurement accuracy across different lighting conditions, movements and cameras.
To support this process, IntelliProve has developed three technologies: VitalMesh, which tracks facial skin during movement; TripleGate, which monitors signal quality throughout the scan; and PulseShape, which uses deep learning to estimate vital signs, including blood pressure, from pulse wave patterns. IntelliProve’s models have been tested and validated on more than six million data points, with its research team contributing to peer-reviewed publications.
Healthcare is at a tipping point. We believe the future of health monitoring is software-first, scalable and accessible to everyone. Our virtual care partners are not just experimenting with IntelliProve, they are building it into the core of their offering. Humanoid robots are next: they are becoming very good at understanding the world around them, and the next step is helping them understand the people within that world. This funding lets us make IntelliProve the health sensing layer for any camera, worldwide, said Joeri Tulkens, co-founder and co-CEO of IntelliProve.
IntelliProve’s ISO 27001-certified technology is already integrated into virtual care, health insurance and wellbeing platforms worldwide, enabling users to monitor health indicators remotely through existing applications without additional medical devices.
The company is now expanding into humanoid and assistive robotics, aiming to enable camera-based health monitoring in homes and care facilities while leaving medical decisions to healthcare professionals. IntelliProve is working with selected robotics partners and sees further potential in devices such as smart glasses and self-service kiosks.
We will keep investing heavily in research, scientific validation and high-quality data, and we want our layer certified in markets around the world. Whether the scan runs on a smartphone or on a humanoid robot, the bar stays the same: the best health sensing layer in the world. said Tanguy Sanglet, co-founder and CTO of IntelliProve.
The new funding will support further research and development, including expanding datasets across different skin tones, age groups, lighting conditions and devices, as well as improving the accuracy of individual biomarkers. IntelliProve will also advance clinical validation and work towards Class IIa medical device certification under the EU Medical Device Regulation, alongside regulatory approvals in markets outside Europe.
In parallel, the company plans to expand its virtual care partnerships and strengthen international collaborations with developers of humanoid and assistive robots.
